CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. (Record no. 27517630)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00625 a2200169 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517172155.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | ####s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2156-6976 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Malaer, Joseph D |
245 00 - TITLE STATEMENT | |
Title | CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | American journal of cancer research |
Date of publication, distribution, etc. | 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1637-1641 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mathew, Porunelloor A |
773 0# - HOST ITEM ENTRY | |
Title | American journal of cancer research |
Related parts | vol. 7 |
-- | no. 8 |
-- | p. 1637-1641 |
No items available.